These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24980111)

  • 1. Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.
    Thus KA; Ruizendaal MT; de Hoop TA; Borst E; van Deutekom HW; Te Boome L; Kuball J; Spierings E
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1705-10. PubMed ID: 24980111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
    Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA-DPB1 typing.
    Stenger W; Künkele A; Niemann M; Todorova K; Pruß A; Schulte JH; Eggert A; Oevermann L
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28127. PubMed ID: 31850671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.
    Fleischhauer K; Fernandez-Viña MA; Wang T; Haagenson M; Battiwalla M; Baxter-Lowe LA; Ciceri F; Dehn J; Gajewski J; Hale GA; Heemskerk MB; Marino SR; McCarthy PL; Miklos D; Oudshoorn M; Pollack MS; Reddy V; Senitzer D; Shaw BE; Waller EK; Lee SJ; Spellman SR
    Bone Marrow Transplant; 2014 Sep; 49(9):1176-83. PubMed ID: 24955785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted Indirectly ReCognizable HLA Epitopes Class I Promote Antileukemia Responses after Cord Blood Transplantation: Indications for a Potential Novel Donor Selection Tool.
    Thus KA; de Hoop TA; de Weger RA; Bierings MB; Boelens JJ; Spierings E
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):170-3. PubMed ID: 26319093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.
    Fleischhauer K; Shaw BE; Gooley T; Malkki M; Bardy P; Bignon JD; Dubois V; Horowitz MM; Madrigal JA; Morishima Y; Oudshoorn M; Ringden O; Spellman S; Velardi A; Zino E; Petersdorf EW;
    Lancet Oncol; 2012 Apr; 13(4):366-74. PubMed ID: 22340965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
    Zou J; Kongtim P; Oran B; Kosmoliaptsis V; Carmazzi Y; Ma J; Li L; Rondon G; Srour S; Copley HC; Partlow D; Ciurea SO; Greenbaum U; Ma Q; Shpall EJ; Champlin RE; Cao K
    Haematologica; 2022 Apr; 107(4):844-856. PubMed ID: 34435482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
    Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
    Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations.
    Geneugelijk K; Thus KA; van Deutekom HWM; Calis JJA; Borst E; Keşmir C; Oudshoorn M; van der Holt B; Meijer E; Zeerleder S; de Groot MR; von dem Borne PA; Schaap N; Cornelissen J; Kuball J; Spierings E
    Front Immunol; 2019; 10():880. PubMed ID: 31068946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation.
    Buhler S; Baldomero H; Ferrari-Lacraz S; Mamez AC; Masouridi-Levrat S; Heim D; Halter J; Nair G; Chalandon Y; Schanz U; Güngör T; Nicoloso G; Passweg JR; Villard J;
    Blood Adv; 2021 Sep; 5(17):3377-3386. PubMed ID: 34448833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.
    Mytilineos D; Tsamadou C; Neuchel C; Platzbecker U; Bunjes D; Schub N; Wagner-Drouet E; Wulf G; Kröger N; Murawski N; Einsele H; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Dürholt M; Hertenstein B; Klein S; Ringhoffer M; Mueller CR; Frank S; Schrezenmeier H; Fuerst D; Mytilineos J
    Front Immunol; 2020; 11():614976. PubMed ID: 33569061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.
    Fleischhauer K; Ahn KW; Wang HL; Zito L; Crivello P; Müller C; Verneris M; Shaw BE; Pidala J; Oudshorn M; Lee SJ; Spellman SR
    Bone Marrow Transplant; 2017 Sep; 52(9):1280-1287. PubMed ID: 28581467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
    Zou J; Kongtim P; Oran B; Srour SA; Greenbaum U; Carmazzi Y; Rondon G; Ciurea SO; Ma Q; Shpall EJ; Champlin RE; Cao K
    Cancer; 2023 Apr; 129(8):1205-1216. PubMed ID: 36738229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.
    Petersdorf EW; Bengtsson M; De Santis D; Dubois V; Fleischhauer K; Gooley T; Horowitz M; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P; Carrington M; ;
    J Clin Oncol; 2020 Aug; 38(24):2712-2718. PubMed ID: 32479188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete donor chimerism is a prerequisite for the effect of Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) on acute graft-versus-host disease.
    Thus KA; de Weger RA; de Hoop TA; Boers Trilles VE; Kuball J; Spierings E
    Chimerism; 2014; 5(3-4):94-8. PubMed ID: 26669207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
    Pidala J; Lee SJ; Ahn KW; Spellman S; Wang HL; Aljurf M; Askar M; Dehn J; Fernandez Viña M; Gratwohl A; Gupta V; Hanna R; Horowitz MM; Hurley CK; Inamoto Y; Kassim AA; Nishihori T; Mueller C; Oudshoorn M; Petersdorf EW; Prasad V; Robinson J; Saber W; Schultz KR; Shaw B; Storek J; Wood WA; Woolfrey AE; Anasetti C
    Blood; 2014 Oct; 124(16):2596-606. PubMed ID: 25161269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Data on PIRCHE and T-Cell Reactivity: HLA-DPB1-Derived Peptides Identified by PIRCHE-I Show Binding to HLA-A*02:01 in vitro and T-Cell Activation in vivo.
    Peereboom ETM; Maranus AE; Timmerman LM; Geneugelijk K; Spierings E
    Transfus Med Hemother; 2024 Jun; 51(3):131-139. PubMed ID: 38867810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.
    Burek Kamenaric M; Maskalan M; Grubic Z; Mikulic M; Serventi Seiwerth R; Durakovic N; Vrhovac R; Stingl Jankovic K; Zunec R
    Hum Immunol; 2017 Nov; 78(11-12):665-671. PubMed ID: 28887054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
    Rimando J; Slade M; DiPersio JF; Westervelt P; Gao F; Liu C; Romee R
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):123-131. PubMed ID: 31563575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk prediction and function evaluation by T-cell epitope model and expression model of HLA-DPB1 mismatching in unrelated-donor hematopoietic stem cell transplantations].
    Qi J; Wang TJ; Wang MN; Shang LX; Chen L; Wang XF; Li YH; Xu H; Ma CF
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(11):850-856. PubMed ID: 38462361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.